USD 25.33
(-3.72%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 2.78 Billion USD | 10.31% |
2022 | 2.52 Billion USD | 23.08% |
2021 | 2.04 Billion USD | 6.28% |
2020 | 1.92 Billion USD | 8.93% |
2019 | 1.77 Billion USD | 60.91% |
2018 | 1.1 Billion USD | -14.13% |
2017 | 1.28 Billion USD | -17.35% |
2016 | 1.55 Billion USD | 13.97% |
2015 | 1.36 Billion USD | -15.53% |
2014 | 1.61 Billion USD | 538.89% |
2013 | 252 Million USD | -13.1% |
2012 | 290 Million USD | 110.14% |
2011 | 138 Million USD | -71.95% |
2010 | 492 Million USD | -49.28% |
2009 | 970 Million USD | -26.96% |
2008 | 1.32 Billion USD | 1.53% |
2007 | 1.3 Billion USD | 716.98% |
2006 | -212 Million USD | -173.87% |
2005 | 287 Million USD | -1.75% |
2004 | 292.12 Million USD | -9.12% |
2003 | 321.42 Million USD | -32.07% |
2002 | 473.15 Million USD | 29.97% |
2001 | 364.05 Million USD | 3.15% |
2000 | 352.93 Million USD | 1078.35% |
1999 | -36.07 Million USD | -143.91% |
1998 | 82.16 Million USD | 6.66% |
1997 | 77.03 Million USD | 4.61% |
1996 | 73.63 Million USD | -41.88% |
1995 | 126.7 Million USD | 1720.92% |
1994 | -7.81 Million USD | -105.07% |
1993 | 154.28 Million USD | 138.22% |
1992 | 64.76 Million USD | -54.58% |
1991 | 142.58 Million USD | -48.24% |
1990 | 275.45 Million USD | -28.11% |
1989 | 383.18 Million USD | 43.88% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 3.08 Billion USD | 0.0% |
2023 Q2 | 2.84 Billion USD | 0.0% |
2023 FY | 2.78 Billion USD | 10.31% |
2023 Q4 | 2.78 Billion USD | 0.0% |
2022 Q4 | 2.52 Billion USD | 0.0% |
2022 Q2 | 2.37 Billion USD | 0.0% |
2022 FY | 2.52 Billion USD | 23.08% |
2021 FY | 2.04 Billion USD | 6.28% |
2021 Q2 | 2.17 Billion USD | 0.0% |
2021 Q4 | 2.04 Billion USD | 0.0% |
2020 Q2 | 2.29 Billion USD | 0.0% |
2020 Q4 | 1.92 Billion USD | 0.0% |
2020 FY | 1.92 Billion USD | 8.93% |
2019 FY | 1.77 Billion USD | 60.91% |
2019 Q4 | 1.77 Billion USD | 0.0% |
2019 Q2 | 2.04 Billion USD | 0.0% |
2018 Q4 | 1.1 Billion USD | 0.0% |
2018 Q2 | 1.4 Billion USD | 0.0% |
2018 FY | 1.1 Billion USD | -14.13% |
2017 FY | 1.28 Billion USD | -17.35% |
2017 Q4 | 1.28 Billion USD | 0.0% |
2017 Q2 | 1.59 Billion USD | 0.0% |
2016 Q4 | 1.55 Billion USD | 0.0% |
2016 FY | 1.55 Billion USD | 13.97% |
2016 Q2 | 1.69 Billion USD | 0.0% |
2015 FY | 1.36 Billion USD | -15.53% |
2015 Q2 | 1.51 Billion USD | 0.0% |
2015 Q4 | 1.36 Billion USD | 0.0% |
2014 Q4 | 1.61 Billion USD | 0.0% |
2014 FY | 1.61 Billion USD | 538.89% |
2014 Q2 | 1.91 Billion USD | 0.0% |
2013 Q4 | 252 Million USD | 0.0% |
2013 Q2 | 282 Million USD | 0.0% |
2013 FY | 252 Million USD | -13.1% |
2012 Q4 | 290 Million USD | 177.13% |
2012 Q1 | 29 Million USD | -78.99% |
2012 FY | 290 Million USD | 110.14% |
2012 Q2 | -150 Million USD | -617.24% |
2012 Q3 | -376 Million USD | -150.67% |
2011 FY | 138 Million USD | -71.95% |
2011 Q4 | 138 Million USD | -33.65% |
2011 Q3 | 208 Million USD | -41.57% |
2011 Q2 | 356 Million USD | 1.14% |
2011 Q1 | 352 Million USD | -28.46% |
2010 Q1 | 783 Million USD | -19.28% |
2010 Q2 | 724 Million USD | -7.54% |
2010 FY | 492 Million USD | -49.28% |
2010 Q3 | 599 Million USD | -17.27% |
2010 Q4 | 492 Million USD | -17.86% |
2009 FY | 970 Million USD | -26.96% |
2009 Q4 | 970 Million USD | -12.85% |
2009 Q2 | 1.24 Billion USD | 8.87% |
2009 Q3 | 1.11 Billion USD | -10.24% |
2009 Q1 | 1.13 Billion USD | -14.23% |
2008 Q3 | 1.39 Billion USD | -7.18% |
2008 FY | 1.32 Billion USD | 1.53% |
2008 Q1 | 1.45 Billion USD | 11.16% |
2008 Q2 | 1.5 Billion USD | 3.51% |
2008 Q4 | 1.32 Billion USD | -4.94% |
2007 Q1 | -205 Million USD | 3.3% |
2007 Q2 | 901 Million USD | 539.51% |
2007 Q4 | 1.3 Billion USD | 15.75% |
2007 Q3 | 1.13 Billion USD | 25.42% |
2007 FY | 1.3 Billion USD | 716.98% |
2006 Q4 | -212 Million USD | -40.4% |
2006 FY | -212 Million USD | -173.87% |
2006 Q1 | -269 Million USD | -252.84% |
2006 Q2 | -230 Million USD | 14.5% |
2006 Q3 | -151 Million USD | 34.35% |
2005 Q4 | 176 Million USD | -35.77% |
2005 Q3 | 274 Million USD | -55.47% |
2005 Q2 | 615.31 Million USD | 128.74% |
2005 Q1 | 269 Million USD | -2.29% |
2005 FY | 287 Million USD | -1.75% |
2004 Q1 | 369.52 Million USD | 14.96% |
2004 FY | 292.12 Million USD | -9.12% |
2004 Q4 | 275.31 Million USD | -19.79% |
2004 Q3 | 343.25 Million USD | -9.82% |
2004 Q2 | 380.62 Million USD | 3.01% |
2003 Q2 | -60.24 Million USD | -111.68% |
2003 Q1 | 515.68 Million USD | 8.99% |
2003 Q3 | - USD | 100.0% |
2003 FY | 321.42 Million USD | -32.07% |
2003 Q4 | 321.42 Million USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q4 | 473.13 Million USD | 0.0% |
2002 FY | 473.15 Million USD | 29.97% |
2001 FY | 364.05 Million USD | 3.15% |
2001 Q2 | - USD | 0.0% |
2001 Q4 | 364.05 Million USD | 0.0% |
2000 Q2 | -219.7 Million USD | 0.0% |
2000 Q4 | 352.93 Million USD | 0.0% |
2000 FY | 352.93 Million USD | 1078.35% |
1999 Q2 | -45.6 Million USD | 0.0% |
1999 Q4 | -36.07 Million USD | 0.0% |
1999 FY | -36.07 Million USD | -143.91% |
1998 FY | 82.16 Million USD | 6.66% |
1997 FY | 77.03 Million USD | 4.61% |
1996 FY | 73.63 Million USD | -41.88% |
1995 FY | 126.7 Million USD | 1720.92% |
1994 FY | -7.81 Million USD | -105.07% |
1993 FY | 154.28 Million USD | 138.22% |
1992 FY | 64.76 Million USD | -54.58% |
1991 FY | 142.58 Million USD | -48.24% |
1990 FY | 275.45 Million USD | -28.11% |
1989 FY | 383.18 Million USD | 43.88% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Abbott Laboratories | 8.97 Billion USD | 69.01% |
Allurion Technologies Inc. | 3.82 Million USD | -72727.225% |
Artivion, Inc. | 300.4 Million USD | -826.095% |
Avanos Medical, Inc. | 121.4 Million USD | -2191.598% |
Butterfly Network, Inc. | -109.6 Million USD | 2638.113% |
Butterfly Network, Inc. | -109.6 Million USD | 2638.113% |
Bio-Rad Laboratories, Inc. | 1 Billion USD | -177.664% |
Boston Scientific Corporation | 8.62 Billion USD | 67.752% |
CONMED Corporation | 966.95 Million USD | -187.706% |
Edwards Lifesciences Corporation | -449.1 Million USD | 719.461% |
Paragon 28, Inc. | 36.39 Million USD | -7544.747% |
Glaukos Corporation | 290.27 Million USD | -858.415% |
Globus Medical, Inc. | 53.11 Million USD | -5137.988% |
Inspire Medical Systems, Inc. | -160.69 Million USD | 1831.273% |
Integer Holdings Corporation | 1.01 Billion USD | -173.474% |
Medtronic plc | 24.76 Billion USD | 88.765% |
Myomo, Inc. | -6.27 Million USD | 44469.995% |
Nevro Corp. | 117.61 Million USD | -2265.445% |
Owlet, Inc. | -1.34 Million USD | 207557.276% |
Penumbra, Inc. | 66.85 Million USD | -4061.12% |
Vicarious Surgical Inc. | -37.99 Million USD | 7422.98% |
Sonendo, Inc. | 26.34 Million USD | -10461.081% |
STERIS plc | 3.17 Billion USD | 12.41% |
Stryker Corporation | 10.02 Billion USD | 72.247% |
Vapotherm, Inc. | 102.66 Million USD | -2609.731% |
Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 50.138% |